deltatrials
Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06705868

Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease. (CHRONOMASLD)

Time-restricted Eating in Patients With Metabolic-associated Steatotic Liver Disease . CHRONOMASLD: A Chrononutrition/Chronotoxicity Randomized Controlled Trial.

Sponsor: Cyprus State Heath Organization Services

Updated 5 times since 2024 Last updated: Nov 18, 2025 Started: Jan 5, 2026 Primary completion: Dec 15, 2027 Completion: Dec 15, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on MASLD and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, this trial is actively recruiting participants. The trial is conducted by Cyprus State Heath Organization Services and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2024 – ~Apr 2025 · 4 months · monthly snapshotNot Yet Recruiting~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Aug 2025 · 3 months · monthly snapshotNot Yet Recruiting~Aug 2025 – ~Dec 2025 · 4 months · monthly snapshotNot Yet Recruiting~Dec 2025 – present · 7 months · monthly snapshotNot Yet Recruiting

Change History

5 versions recorded
  1. Dec 2025 — Present [monthly]

    Not Yet Recruiting NA

  2. Aug 2025 — Dec 2025 [monthly]

    Not Yet Recruiting NA

  3. May 2025 — Aug 2025 [monthly]

    Not Yet Recruiting NA

  4. Apr 2025 — May 2025 [monthly]

    Not Yet Recruiting NA

  5. Dec 2024 — Apr 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cyprus State Heath Organization Services
  • Cyprus University of Technology
Data source: Cyprus University of Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations